drugset / Trial / NCT04738955

Efficacy and Safety of Micafungin for Injection in Prevention and Treatment of Fungal Infection in Hematological Tumors

NCT04738955

Phase 4 Unknown 230 enrolled Shandong Provincial Hospital
NaSingle-groupOpen-labelTreatment

Summary

This is a multi-center, prospective, open, observational and optimal clinical research to evaluate the clinical effectiveness and safety of different doses of micafungin sodium for injection in patients with hematological tumors.

Timeline

Start
2021-02-01
Primary completion
2023-01-01
Completion
2023-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Micafungin Peptide 100 mg Intravenous
Subject Micafungin Peptide 200 mg Intravenous
Subject Micafungin Peptide 300 mg Intravenous